Mathieu, Patrick

Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk

Després, J.-P., Lemieux, I., Bergeron, J., Pibarot, P., Mathieu, P., Larose, E., Rodés-Cabau, J., Bertrand, O. F., & Poirier, P. (2008) · Arteriosclerosis Thrombosis and Vascular Biology

Diabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic Diseases

Cited by 1,589

Calcific aortic stenosis

Lindman, B. R., Clavel, M.-A., Mathieu, P., Iung, B., Lancellotti, P., Otto, C. M., & Pibarot, P. (2016) · Nature Reviews Disease Primers

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 982

Calcific Aortic Valve Disease: Not Simply a Degenerative Process: A Review and Agenda for Research From the National Heart and Lung and Blood Institute Aortic Stenosis Working Group Executive Summary: Calcific Aortic Valve Disease – 2011 Update

Rajamannan, N. M., Evans, F. J., Aikawa, E., Grande-Allen, K. J., Demer, L. L., Heistad, D. D., Simmons, C. A., Masters, K. S., Mathieu, P., O'Brien, K. D., et al. (2011) · Circulation

Cardiac Valve Diseases and TreatmentsCardiac Imaging and Diagnostics

Cited by 842

Bicuspid Aortic Valve: Identifying Knowledge Gaps and Rising to the Challenge From the International Bicuspid Aortic Valve Consortium (BAVCon)

Michelena, H. I., Prakash, S. K., Della Corte, A., Bissell, M. M., Anavekar, N., Mathieu, P., Bossé, Y., Limongelli, G., Bossone, E., Benson, D. W., et al. (2014) · Circulation

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 442

Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis

Capoulade, R., Chan, K. L., Yeang, C., Mathieu, P., Bossé, Y., Dumesnil, J. G., Tam, J. W., Teo, K. K., Mahmut, A., Yang, X., et al. (2015) · Journal of the American College of Cardiology

Cardiac Valve Diseases and TreatmentsAtherosclerosis and Cardiovascular Diseases

Cited by 417

Calcific aortic valve disease: mechanisms, prevention and treatment

Moncla, L.-H. M., Briend, M., Bossé, Y., & Mathieu, P. (2023) · Nature Reviews Cardiology

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 306

Sex-Related Discordance Between Aortic Valve Calcification and Hemodynamic Severity of Aortic Stenosis: Is Valvular Fibrosis the Explanation?

Simard, L., Côté, N., Dagenais, F., Mathieu, P., Couture, C., Trahan, S., Bossé, Y., Mohammadi, S., Pagé, S., Joubert, P., et al. (2017) · Circulation Research

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 294

Inflammation Is Associated with the Remodeling of Calcific Aortic Valve Disease

Coté, N., Mahmut, A., Bosse, Y., Couture, C., Pagé, S., Trahan, S., Boulanger, M.-C., Fournier, D., Pibarot, P., & Mathieu, P. (2013) · Inflammation

Cardiac Valve Diseases and TreatmentsStreptococcal Infections and Treatments

Cited by 218

Stress Echocardiography to Assess Stenosis Severity and Predict Outcome in Patients With Paradoxical Low-Flow, Low-Gradient Aortic Stenosis and Preserved LVEF

Clavel, M.-A., Ennezat, P. V., Maréchaux, S., Dumesnil, J. G., Capoulade, R., Hachicha, Z., Mathieu, P., Bellouin, A., Bergeron, S., Meimoun, P., et al. (2013) · JACC: Cardiovascular Imaging

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 206

Association Between Plasma LDL Particle Size, Valvular Accumulation of Oxidized LDL, and Inflammation in Patients With Aortic Stenosis

Mohty, D., Pibarot, P., Després, J.-P., Côté, C., Arsenault, B., Cartier, A., Cosnay, P., Couture, C., & Mathieu, P. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology

Cardiac Valve Diseases and TreatmentsAtherosclerosis and Cardiovascular Diseases

Cited by 181

P2Y2 receptor represses IL-6 expression by valve interstitial cells through Akt: implication for calcific aortic valve disease

El Husseini, D., Boulanger, M.-C., Mahmut, A., Bouchareb, R., Laflamme, M.-H., Fournier, D., Pibarot, P., Bossé, Y., & Mathieu, P. (2014) · Journal of Molecular and Cellular Cardiology

Cardiac Valve Diseases and TreatmentsAdenosine and Purinergic Signaling

Cited by 150

Refining molecular pathways leading to calcific aortic valve stenosis by studying gene expression profile of normal and calcified stenotic human aortic valves

Bossé, Y., Miqdad, A., Fournier, D., Pépin, A., Pibarot, P., & Mathieu, P. (2009) · Circulation: Cardiovascular Genetics

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 148

A transcriptome-wide association study identifies PALMD as a susceptibility gene for calcific aortic valve stenosis

Thériault, S., Gaudreault, N., Lamontagne, M., Rosa, M., Boulanger, M.-C., Messika-Zeitoun, D., Clavel, M.-A., Capoulade, R., Dagenais, F., Pibarot, P., et al. (2018) · Nature Communications

Cardiac Valve Diseases and TreatmentsGenetic Associations and Epidemiology

Cited by 135

Impact of Metabolic Syndrome on Progression of Aortic Stenosis

Capoulade, R., Clavel, M.-A., Dumesnil, J. G., Chan, K. L., Teo, K. K., Tam, J. W., Côté, N., Mathieu, P., Després, J.-P., & Pibarot, P. (2012) · Journal of the American College of Cardiology

Cardiac Valve Diseases and TreatmentsCardiovascular Function and Risk Factors

Cited by 127

Age, Sex, and Valve Phenotype Differences in Fibro‐Calcific Remodeling of Calcified Aortic Valve

Voisine, M., Hervault, M., Shen, M., Boilard, A., Filion, B., Rosa, M., Bossé, Y., Mathieu, P., Côté, N., & Clavel, M. (2020) · Journal of the American Heart Association

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 124

Innate and Adaptive Immunity in Calcific Aortic Valve Disease

Mathieu, P., Bouchareb, R., & Boulanger, M.-C. (2015) · Journal of Immunology Research

Cardiac Valve Diseases and TreatmentsAtherosclerosis and Cardiovascular Diseases

Cited by 121

Basic Mechanisms of Calcific Aortic Valve Disease

Mathieu, P., & Boulanger, M.-C. (2014) · Canadian Journal of Cardiology

Cardiac Valve Diseases and TreatmentsAtherosclerosis and Cardiovascular Diseases

Cited by 107

Metabolic Syndrome Is Associated With More Pronounced Impairment of Left Ventricle Geometry and Function in Patients With Calcific Aortic Stenosis

Pagé, A., Dumesnil, J. G., Clavel, M.-A., Chan, K. L., Teo, K. K., Tam, J. W., Mathieu, P., Després, J.-P., & Pibarot, P. (2010) · Journal of the American College of Cardiology

Cardiovascular Function and Risk FactorsCardiac Valve Diseases and Treatments

Cited by 102

Systolic hypertension and progression of aortic valve calcification in patients with aortic stenosis: results from the PROGRESSA study

Tastet, L., Capoulade, R., Clavel, M.-A., Larose, É., Shen, M., Dahou, A., Arsenault, M., Mathieu, P., Bédard, É., Dumesnil, J. G., et al. (2017) · European Heart Journal – Cardiovascular Imaging

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 100

Impact of hypertension and renin–angiotensin system inhibitors in aortic stenosis

Capoulade, R., Clavel, M., Mathieu, P., Côté, N., Dumesnil, J. G., Arsenault, M., Bédard, É., & Pibarot, P. (2013) · European Journal of Clinical Investigation

Cardiac Valve Diseases and TreatmentsRenin-Angiotensin System Studies

Cited by 97

ATP acts as a survival signal and prevents the mineralization of aortic valve

Côté, N., El Husseini, D., Pépin, A., Guauque-Olarte, S., Ducharme, V., Bouchard-Cannon, P., Audet, A., Fournier, D., Gaudreault, N., Derbali, H., et al. (2012) · Journal of Molecular and Cellular Cardiology

Adenosine and Purinergic SignalingCardiac Valve Diseases and Treatments

Cited by 95

Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis

Perrot, N., Valerio, V., Moschetta, D., Boekholdt, S. M., Dina, C., Chen, H. Y., Abner, E., Martinsson, A., Manikpurage, H. D., Rigade, S., et al. (2020) · JACC: Basic to Translational Science

Cardiac Valve Diseases and TreatmentsDermatological and Skeletal Disorders

Cited by 91

Genetic Association Analyses Highlight IL6 , ALPL , and NAV1 As 3 New Susceptibility Genes Underlying Calcific Aortic Valve Stenosis

Thériault, S., Dina, C., Messika-Zeitoun, D., Le Scouarnec, S., Capoulade, R., Gaudreault, N., Rigade, S., Li, Z., Simonet, F., Lamontagne, M., et al. (2019) · Circulation: Genomic and Precision Medicine

Cardiac Valve Diseases and TreatmentsGenetic Associations and Epidemiology

Cited by 90

Genomics

Bossé, Y., Mathieu, P., & Pibarot, P. (2008) · Journal of the American College of Cardiology

Cardiac Valve Diseases and TreatmentsGenetic Associations and Epidemiology

Cited by 82